Prasad V Bharatam

发表

Divalent NI Compounds: Identifying new Carbocyclic Carbenes to Design Nitreones using Quantum Chemical Methods

Shweta Bhagat, Tejender Singh, Neha Patel, 2020, J. Comput. Chem..

Donor→acceptor coordination interactions in 1,3‐bis(NHC)triazenyl Cations: An electronic structure analysis

Tejender Singh, Prasad V Bharatam, P. Bharatam, 2019, J. Comput. Chem..

Pharmacoinformatic approaches to understand complexation of dendrimeric nanoparticles with drugs.

Vaibhav Jain, Prasad V Bharatam, V. Jain, 2014, Nanoscale.

Important pharmacophoric features of pan PPAR agonists: common chemical feature analysis and virtual screening.

Prasad V Bharatam, P. Bharatam, S. Sundriyal, 2009, European journal of medicinal chemistry.

CoMFA analysis of dual/multiple PPAR activators.

Prasad V Bharatam, P. Bharatam, A. Mittal, 2008, European journal of medicinal chemistry.

Atomic level insights into realistic molecular models of dendrimer-drug complexes through MD simulations.

Vaibhav Jain, Prasad V Bharatam, Prabal K Maiti, 2016, The Journal of chemical physics.

New PPARgamma ligands based on 2-hydroxy-1,4-naphthoquinone: computer-aided design, synthesis, and receptor-binding studies.

Prasad V Bharatam, Asit K Chakraborti, P. Ramarao, 2008, Bioorganic & medicinal chemistry letters.

Identification of potential glycogen kinase-3 inhibitors by structure based virtual screening.

Prasad V Bharatam, N. Dessalew, P. Bharatam, 2007, Biophysical chemistry.

3D-QSAR studies of pyruvate dehydrogenase kinase inhibitors based on a divide and conquer strategy.

Prasad V Bharatam, P. Bharatam, M Elizabeth Sobhia, 2004, Bioorganic & medicinal chemistry.

New PPARgamma ligands based on barbituric acid: virtual screening, synthesis and receptor binding studies.

Prasad V Bharatam, Asit K Chakraborti, P. Ramarao, 2008, Bioorganic & medicinal chemistry letters.

Modelling and informatics in the analysis of P. falciparum DHFR enzyme inhibitors.

Prasad V Bharatam, Legesse Adane, P. Bharatam, 2008, Current medicinal chemistry.

'Sum of activities' as dependent parameter: a new CoMFA-based approach for the design of pan PPAR agonists.

Prasad V Bharatam, P. Bharatam, S. Sundriyal, 2009, European journal of medicinal chemistry.

N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase.

Amit Agarwal, Vaibhav Jain, Prasad V Bharatam, 2011, Journal of medicinal chemistry.